Repurposing proton pump inhibitors to restore ceftriaxone activity against multidrug-resistant Klebsiella pneumoniae: phenotypic, molecular, and in silico evidence
Naunyn-Schmiedeberg's Archives of Pharmacology · 04.11.2026
DOI: 10.1007/s00210-026-06036-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 04.11.2026. Verfasst von Eftkhar Muhammad Hussein und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Science, Mustansiriyah University, Baghdad, Iraq. stbg@uomustansiriyah.edu.iq. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Klebsiella pneumoniae has emerged as one of the most clinically significant multidrug-resistant (MDR) pathogens, with multidrug efflux systems playing a pivotal role in antibiotic resistance and therapeutic failure. This study investigated the contribution of the efflux-associated genes kpnE , kmrA , and kdeA to ceftriaxone resistance and evaluated proton pump inhibitors (PPIs) as efflux pump-targeting adjuvants. Fifty clinical K. pneumoniae isolates were characterized by antimicrobial susceptibility testing, MDR/XDR classification, phenotypic efflux activity assays, molecular detection of efflux-associated genes, kpnE sequencing, quantitative real-time PCR, molecular docking, and ceftriaxone minimum inhibitory concentration (MIC) determination in the presence and absence of omeprazole and lansoprazole. MDR and XDR phenotypes were identified in 70% and 18% of isolates, respectively, whereas active efflux was detected in 14% of isolates and was significantly associated with increasing resistance severity. Sequence analysis demonstrated marked conservation of kpnE, with a single D → G amino acid substitution identified in one isolate. Despite this conservation, gene expression analysis revealed substantial isolate-dependent transcriptional responses that were not directly correlated with phenotypic efflux activity, suggesting that transporter efficiency is governed by complex interactions between transcriptional regulation, structural adaptation, and protein functionality rather than gene expression alone. Molecular docking demonstrated favorable binding of both PPIs to KpnE, KmrA, and KdeA, supporting their potential to interfere with efflux-mediated drug extrusion. Consistent with these predictions, combination assays markedly potentiated ceftriaxone activity, reducing MIC values by up to 16,516-fold and restoring ceftriaxone susceptibility in all seven tested efflux-active ceftriaxone-resistant isolates, with omeprazole producing the greatest synergistic effect. Collectively, these findings provide new mechanistic insight into the role of SMR-associated efflux systems in K. pneumoniae antimicrobial resistance and identify proton pump inhibitors, particularly omeprazole, as potential antibiotic adjuvants for restoring β-lactam efficacy against MDR and XDR K. pneumoniae . Further functional and in vivo studies are warranted to determine whether these in vitro findings can be translated into clinically relevant therapeutic applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biology, College of Science, Mustansiriyah University, Baghdad, Iraq. stbg@uomustansiriyah.edu.iq.
- Department of Biology, College of Science, Mustansiriyah University, Baghdad, Iraq.
Zitieren
APA
Hussein, E. M., & Auda, I. G. (2026). Repurposing proton pump inhibitors to restore ceftriaxone activity against multidrug-resistant Klebsiella pneumoniae: phenotypic, molecular, and in silico evidence. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-06036-8
Vancouver
Hussein EM, Auda IG. Repurposing proton pump inhibitors to restore ceftriaxone activity against multidrug-resistant Klebsiella pneumoniae: phenotypic, molecular, and in silico evidence. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-06036-8
BibTeX
@article{Hussein2026,
author = {Hussein, Eftkhar Muhammad and Auda, Ibtesam Ghadban},
title = {Repurposing proton pump inhibitors to restore ceftriaxone activity against multidrug-resistant Klebsiella pneumoniae: phenotypic, molecular, and in silico evidence},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-026-06036-8}
}
EUVIMED